November 30, 2023 Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
November 30, 2023 2023 C-Path Neuroscience Annual Meeting C-Path’s 2023 Neuroscience Program Annual Meeting is set for Thursday, November 30 in Washington D.C. Bringing stakeholders....
November 29, 2023 C-Path’s Translational Therapeutics Accelerator and Celdara Medical Announce Pipeline-focused MOU TUCSON, Ariz. and LEBANON, N.H., November 29, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator
November 21, 2023 Successfully Navigating the Valley of Death: the Importance of Accelerators in Drug Discovery and Development
November 21, 2023 Use of Registries in Regulatory Decision Making The C-Path team is working to revolutionize the use of real-world data in sharing the future of medical product development in...
November 16, 2023 VCP Disease(s), an Integrated Approach to Neurodegenerative Disorders In this webinar from Critical Path Institute’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), speake
November 16, 2023 Poster: C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
November 16, 2023 eCOA Holds Annual Meeting in Denmark C-Path’s eCOA Consortium convened in Copenhagen, Denmark for its EU face-to-face meeting on Thursday, November 16. The eCOA...
November 9, 2023 C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publica
